Avaliação Económica de Fidaxomicina no Tratamento de Infeções por Clostridium Difficile Graves ou Recorrentes
Objectives: Fidaxomicin is a macrocyclic antibiotic drug indicated for the treatment of Clostridium difficile infections (CDI). The purpose of this study was to evaluate from a societal perspective the cost-effectiveness and cost-utility of fidaxomicin in the treatment of severe or recurrent CDI com...
Saved in:
| Main Authors: | , , , |
|---|---|
| 格式: | 图书 |
| 出版: |
Formifarma, LDA.,
2013-10-01T00:00:00Z.
|
| 主题: | |
| 在线阅读: | Connect to this object online. |
| 标签: |
添加标签
没有标签, 成为第一个标记此记录!
|
因特网
Connect to this object online.3rd Floor Main Library
| 索引号: |
A1234.567 |
|---|---|
| 复印件 1 | 可用 |